Cancer Gene Therapy

Papers
(The H4-Index of Cancer Gene Therapy is 27. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-03-01 to 2024-03-01.)
ArticleCitations
Revisiting the role of CD4+ T cells in cancer immunotherapy—new insights into old paradigms423
Key chemokines direct migration of immune cells in solid tumors179
Cancer-associated fibroblasts: overview, progress, challenges, and directions153
Transcription factors in ferroptotic cell death135
Interplay between MTOR and GPX4 signaling modulates autophagy-dependent ferroptotic cancer cell death124
METTL3-mediated maturation of miR-126-5p promotes ovarian cancer progression via PTEN-mediated PI3K/Akt/mTOR pathway95
TMB: a promising immune-response biomarker, and potential spearhead in advancing targeted therapy trials87
The KRAS-G12C inhibitor: activity and resistance61
ESCRT-III-mediated membrane repair in cell death and tumor resistance52
LOX-1 and cancer: an indissoluble liaison49
Use of CAR T-cell for acute lymphoblastic leukemia (ALL) treatment: a review study47
HDAC3-dependent transcriptional repression of FOXA2 regulates FTO/m6A/MYC signaling to contribute to the development of gastric cancer47
Nanomedicine-based cancer immunotherapy: recent trends and future perspectives42
Roles of miRNA dysregulation in the pathogenesis of multiple myeloma39
Expression pattern of m6A regulators is significantly correlated with malignancy and antitumor immune response of breast cancer38
Hsa_circRNA_102002 facilitates metastasis of papillary thyroid cancer through regulating miR-488-3p/HAS2 axis37
Autophagy and gastrointestinal cancers: the behind the scenes role of long non-coding RNAs in initiation, progression, and treatment resistance36
Combination therapy with CAR T cells and oncolytic viruses: a new era in cancer immunotherapy34
Mesenchymal stem cell (MSC)-derived exosomes as novel vehicles for delivery of miRNAs in cancer therapy34
CXCR4 and anti-BCMA CAR co-modified natural killer cells suppress multiple myeloma progression in a xenograft mouse model33
TCR-like CARs and TCR-CARs targeting neoepitopes: an emerging potential33
Oncolytic adenoviruses synergistically enhance anti-PD-L1 and anti-CTLA-4 immunotherapy by modulating the tumour microenvironment in a 4T1 orthotopic mouse model32
Exosomal LINC00161 promotes angiogenesis and metastasis via regulating miR-590-3p/ROCK axis in hepatocellular carcinoma31
Extracellular vesicles-encapsulated microRNA-10a-5p shed from cancer-associated fibroblast facilitates cervical squamous cell carcinoma cell angiogenesis and tumorigenicity via Hedgehog signaling path29
GINS2 promotes EMT in pancreatic cancer via specifically stimulating ERK/MAPK signaling28
Cytokine-enhanced cytolytic activity of exosomes from NK Cells27
LncRNA LINC01857 promotes cell growth and diminishes apoptosis via PI3K/mTOR pathway and EMT process by regulating miR-141-3p/MAP4K4 axis in diffuse large B-cell lymphoma27
0.031707048416138